The Biological Rationale for Next-Generation Sequencing and Precision Oncology within the France Contract Research Organization Sector for 2025
The demand for specialized oncology trials in France has surged in late 2025, driven by the integration of Next-Generation Sequencing (NGS) into standard clinical research protocols. Contract research entities are increasingly tasked with managing "basket" and "umbrella" trials that group patients based on molecular biomarkers rather than traditional tumor locations. This shift requires a high...
0 Commenti 0 condivisioni 15 Views 0 Anteprima